Arvinas (ARVN) Operating Expenses (2017 - 2026)
Arvinas (ARVN) recorded quarterly Operating Expenses of $79.4 million in Q1 2026, down 5.59% quarter-over-quarter from $84.1 million in Q4 2025, and down 32.37% on a YoY basis from $117.4 million in Q1 2025.
Arvinas (ARVN) Operating Expenses (2017 - 2026) Analysis & Trends
Arvinas' Operating Expenses history runs 10 years deep, the most recent figure standing at $79.4 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 32.37% year-over-year to $79.4 million; the TTM figure through Mar 2026 stood at $343.1 million (down 34.33% YoY), while the FY2025 annual figure was $381.1 million, down 25.8% from the prior year.
- Operating Expenses was $79.4 million for Q1 2026 at Arvinas, down from $84.1 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $162.7 million in Q3 2024 to a low of $79.4 million in Q1 2026.
- Historically, Operating Expenses has averaged $108.8 million across 5 years, with a median of $108.6 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses jumped 78.39% in 2022, then tumbled 47.33% in 2025.
- A 5-year view of Operating Expenses shows it stood at $113.4 million in 2022, then grew by 7.76% to $122.2 million in 2023, then decreased by 3.93% to $117.4 million in 2024, then dropped by 28.36% to $84.1 million in 2025, then decreased by 5.59% to $79.4 million in 2026.
- The last three Operating Expenses figures came in at $79.4 million (Q1 2026), $84.1 million (Q4 2025), and $85.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 79.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.40 Mn |
| Dec 31, 2025 | 84.10 Mn |
| Sep 30, 2025 | 85.70 Mn |
| Jun 30, 2025 | 93.90 Mn |
| Mar 31, 2025 | 117.40 Mn |
| Dec 31, 2024 | 117.40 Mn |
| Sep 30, 2024 | 162.70 Mn |
| Jun 30, 2024 | 125.00 Mn |
| Mar 31, 2024 | 108.60 Mn |
| Dec 31, 2023 | 122.20 Mn |
| Sep 30, 2023 | 108.50 Mn |
| Jun 30, 2023 | 129.10 Mn |
| Mar 31, 2023 | 120.20 Mn |
| Dec 31, 2022 | 113.40 Mn |
| Sep 30, 2022 | 97.50 Mn |
| Jun 30, 2022 | 99.60 Mn |
| Mar 31, 2022 | 84.20 Mn |
| Dec 31, 2021 | 80.70 Mn |
| Sep 30, 2021 | 56.60 Mn |
| Jun 30, 2021 | 57.40 Mn |